AIM: To identify perinatal factors associated with sub-optimal neuromotor outcome in infants without evident central nervous system lesions (intraventricular hemorrhage/ periventricular leukomalacia), with gestational age ≤30 (group I) and of 31-32 weeks (group II). PATIENTS AND METHODS: A total of 102 premature infants admitted to the Neonatal Intensive Care Unit of Pisa, at 26-32 weeks of gestation, were studied. Data about perinatal factors and TSH values at 3-4 days of life were collected. The assessment of neuromotor development was performed at 18 months of corrected age, using the locomotor subscale of the Griffiths Scales of Mental Development. RESULTS: Risk factors supposed to be predictive of sub-optimal neuromotor outcome (odds ratio >1) were at ≤30 weeks: male sex, small for gestational age, patent duct arterious, respiratory distress syndrome, and at 31-32 weeks: Apgar at 5 min <7, respiratory distress syndrome, patent duct arterious and birth weight <1500 g. A strong correlation was also found between TSH screening values >4,3 mU/l and suboptimal neuromotor outcome in both groups. CONCLUSIONS: Several perinatal factors, acting on an immature and more vulnerable nervous system, such as the pre-term one, different for different gestational ages, are associated with a sub-optimal neuromotor outcome. Higher, but within the normal range, TSH values at screening seem to be a strong risk factor for neuromotor outcome in preterm infants without intraventricular hemorrhage or periventricular leukomalacia.
AIM: To identify perinatal factors associated with sub-optimal neuromotor outcome in infants without evident central nervous system lesions (intraventricular hemorrhage/ periventricular leukomalacia), with gestational age ≤30 (group I) and of 31-32 weeks (group II). PATIENTS AND METHODS: A total of 102 premature infants admitted to the Neonatal Intensive Care Unit of Pisa, at 26-32 weeks of gestation, were studied. Data about perinatal factors and TSH values at 3-4 days of life were collected. The assessment of neuromotor development was performed at 18 months of corrected age, using the locomotor subscale of the Griffiths Scales of Mental Development. RESULTS: Risk factors supposed to be predictive of sub-optimal neuromotor outcome (odds ratio >1) were at ≤30 weeks: male sex, small for gestational age, patent duct arterious, respiratory distress syndrome, and at 31-32 weeks: Apgar at 5 min <7, respiratory distress syndrome, patent duct arterious and birth weight <1500 g. A strong correlation was also found between TSH screening values >4,3 mU/l and suboptimal neuromotor outcome in both groups. CONCLUSIONS: Several perinatal factors, acting on an immature and more vulnerable nervous system, such as the pre-term one, different for different gestational ages, are associated with a sub-optimal neuromotor outcome. Higher, but within the normal range, TSH values at screening seem to be a strong risk factor for neuromotor outcome in preterm infants without intraventricular hemorrhage or periventricular leukomalacia.
Authors: S Ares; H F Escobar-Morreale; J Quero; S Durán; M J Presas; R Herruzo; G Morreale de Escobar Journal: J Clin Endocrinol Metab Date: 1997-06 Impact factor: 5.958
Authors: Richard A Ehrenkranz; Anna M Dusick; Betty R Vohr; Linda L Wright; Lisa A Wrage; W Kenneth Poole Journal: Pediatrics Date: 2006-04 Impact factor: 7.124
Authors: J L Wémeau; M Pigeyre; E Proust-Lemoine; M d'Herbomez; F Gottrand; J Jansen; T J Visser; M Ladsous Journal: J Clin Endocrinol Metab Date: 2008-03-11 Impact factor: 5.958
Authors: Marcos Abalovich; Nobuyuki Amino; Linda A Barbour; Rhoda H Cobin; Leslie J De Groot; Daniel Glinoer; Susan J Mandel; Alex Stagnaro-Green Journal: J Clin Endocrinol Metab Date: 2007-08 Impact factor: 5.958
Authors: Steven J Korzeniewski; Carmen L Soto-Rivera; Raina N Fichorova; Elizabeth N Allred; Karl C K Kuban; T Michael O'Shea; Nigel Paneth; Michael Agus; Olaf Dammann; Alan Leviton Journal: J Pediatr Endocrinol Metab Date: 2014-11 Impact factor: 1.634
Authors: Caroline Trumpff; Johan Vanderfaeillie; Nathalie Vercruysse; Jean De Schepper; Jean Tafforeau; Herman Van Oyen; Stefanie Vandevijvere Journal: Arch Public Health Date: 2014-08-18
Authors: Caroline Trumpff; Jean De Schepper; Johan Vanderfaeillie; Nathalie Vercruysse; Jean Tafforeau; Herman Van Oyen; Stefanie Vandevijvere Journal: Front Endocrinol (Lausanne) Date: 2016-12-19 Impact factor: 5.555
Authors: Caroline Trumpff; Jean De Schepper; Johan Vanderfaeillie; Nathalie Vercruysse; Herman Van Oyen; Rodrigo Moreno-Reyes; Jean Tafforeau; Stefanie Vandevijvere Journal: Arch Dis Child Date: 2016-07-08 Impact factor: 3.791